tru Weight Loss review

You cannot find out what a quarter dose costs here, because not one milligram figure appears anywhere on the page. What you get instead is two plain package prices with no hedge and no ladder to decode, which is worth something — and tru states its three-month minimum openly in its own FAQ rather than springing it at checkout. It includes lab work and a first consultation in the price, and it names a real physician at a real clinic address instead of gesturing at a network of providers. Two things will cost you. The advertised rate is not month-to-month: you are committed for a quarter before you can cancel, and nothing says whether the rate holds afterwards. And the headline claim — up to twenty percent of body weight in four months — is a seventy-two-week trial result, which is about seventeen months, not four.

Vs median

$130/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Standard plan, self-directed low dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

tru Weight Loss does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

tru Weight Loss sells compounded semaglutide and compounded tirzepatide as weekly injections in two packages, each including the medication, monthly physician supervision and nutrition support. Prices are published openly with no starting-at hedge and no prepay ladder, though a three-month minimum subscription applies before cancellation. It operates from a physical clinic at 12321 Middlebrook Road, Germantown, Maryland, with Neha Grover, MD named as the physician, and includes a free initial telehealth consultation and free lab work in the package price. No compounding pharmacy is named.

NOT ONE MILLIGRAM FIGURE APPEARS ANYWHERE ON THE PAGE, and no dose statement of any kind is published in either direction, so what a low dose costs cannot be established before paying

• THE HEADLINE CLAIM COMPRESSES THE TRIAL. "Lose Up To 20% Of Your Body Weight In Just 4 Months", repeated as "patients, on average, lose up to 20.9% of body weight in just four months" — the 20.9% figure is the SURMOUNT-1 tirzepatide result at 72 weeks, about seventeen months rather than four
• THE ADVERTISED RATE IS NOT MONTH-TO-MONTH: "A 3 month subscription is required after which you can cancel at any time"
• "We do not accept insurance, HSA or FSA cards at this time"
• No week count is published against "a month", so an annual cost cannot be computed
• Whether the $299 and $399 rates hold after the required three-month term is not stated
• No compounding pharmacy is named — only "sourced from US-licensed compounding pharmacies"
• States served are not published
• The footer reads "Copyright 2024"
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

tru Weight Loss is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan